Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Sarcoma × eribulin × Clear all

Status

Sponsor Class

Study Type

Interventional 13 Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 8 Sarcoma 1 Peripheral Nervous System Diseases 1 Neoplasm Metastasis 1 Breast Cancer Organoids 1

Interventions

Gene Expression Profiling 8 Surveys and Questionnaires 5 Polymerase Chain Reaction 5 Blood Specimen Collection 5 Surgical Procedures, Operative 4 Microarray Analysis 4 Immunohistochemistry 4 Base Sequence 4 Trabectedin 3 Therapeutics 3 Reverse Transcriptase Polymerase Chain Reaction 3 Observation 3 Radiation 2 Psychiatric Rehabilitation 2 In Situ Hybridization, Fluorescence 2 Gene Rearrangement 2 Drug Therapy 2 DNA Methylation 2 Amplified Fragment Length Polymorphism Analysis 2 trastuzumab deruxtecan 1 pazopanib 1 liposomal doxorubicin 1 eribulin 1 Watchful Waiting 1 Ropivacaine 1 Referral and Consultation 1 Radiotherapy 1 Radionuclide Imaging 1 Radiation, Ionizing 1 Quality Assurance, Health Care 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03058406 2020-04-06

HAL03T

Eisai Inc.

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡